In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lori Ellis

Custom Content Writer

Orlando, FL

Lori is the content writer within Pharma Intelligence’s Custom Content team, providing clients with engaging content to support their marketing objectives. In addition to providing written content, her camera and voiceover acting and hosting experience – on national campaigns and projects – gives her the ability to specialize in producing, moderating and hosting podcasts, webinars and roundtables. Areas she has covered span the drug development process, from pre-clinical to commercial stages. Her expertise focuses on technology’s ever-evolving impact on the pharmaceutical industry.

Latest From Lori Ellis

An Intelligent Approach To Pain Management

With all of the advancements in the life sciences industry, there is one area that is still assessed the way it has been for 100 years, subjectively. Pain. Gilat Zuckerman-Stark’s vision to improve patient outcomes comes from combining patience, persistence, education and artificial intelligence.

Patient Monitoring Artificial Intelligence

Leading By Example: A Starting Point To Address Disparities In Health Care

As the head of inclusive investments and partnerships lead for Publicis Health Media, Karima Sharif’s expertise in media and strategy has led to the development of rich relationships. She oversees partnerships with more than 600 firms, ranging from lifestyle groups – such as NBC – to endemic HCP partners, such as the New England Journal of Medicine and WebMD

Commercial Business Strategies

Transforming Cancer Drug Development Via Artificial Intelligence

Using a simulation-based drug discovery platform, Turbine is dramatically reshaping drug discovery and development, explains CEO and co-founder Szabolcs Nagy, a 2021 Rising Leader.

Innovation Rising Leaders
See All